Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive declineP. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman et al.|Neurology|2012Cited by 228
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer DiseaseRonald S. Black, Michael Grundman, Reisa A. Sperling et al.|Alzheimer Disease & Associated Disorders|2010Cited by 168
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson’s DiseaseMilton H. Werner, Aaron Ellenbogen, Jacqueline Pellecchia et al.|Journal of Parkinson s Disease|2024Cited by 7